ArticleCureus2025
Hypercalcemia in Patients After Kidney Transplantation.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mineral and bone disorders are common complications of chronic kidney disease. Persistent hyperparathyroidism can develop after kidney transplantation (KTx), often within the first year, and may lead to hypercalcemia that can negatively impact graft function. This retrospective study aimed to assess the prevalence of hypercalcemia within the first three years following KTx and evaluate its impact on renal graft filtration function. Eighty-four patients (29 women, 55 men; mean age 53 ± 13 years) were included. Total calcium and creatinine levels were measured during the first, second, and third year post-transplantation. Statistical analyses were performed using the MedCalc software (MedCalc Software Ltd., Ostend, Belgium). Hypercalcemia was observed in 16 (19.1%) patients at one year, 14 (16.7%) at two years, and 17 (20.2%) at three years post-transplantation. A gradual and statistically significant increase in total and ionized calcium levels was noted over three years. No significant correlation was found between ionized calcium and serum creatinine or estimated glomerular filtration rate (eGFR) in any period analyzed. Hypercalcemia is a common finding after KTx, with increasing calcium levels observed over time. Although no significant association with graft function was identified, further long-term studies are warranted. Routine laboratory monitoring for hypercalcemia and hyperparathyroidism in kidney transplant recipients is recommended, in accordance with KDIGO guidelines.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.